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The microbiota plays an integral role in shaping physical and functional aspects of the
skin. While a healthy microbiota contributes to the maintenance of immune homeostasis,
dysbiosis can result in the development of diverse skin pathologies. This dichotomous
feature of the skin microbiota holds true not only for bacteria, but also for fungi that
colonize the skin. As such, the yeast Malassezia, which is by far the most abundant
component of the skin mycobiota, is associated with a variety of skin disorders, of which
some can be chronic and severe and have a significant impact on the quality of life of
those affected. Understanding the causative relationship between Malassezia and the
development of such skin disorders requires in-depth knowledge of the mechanism by
which the immune system interacts with and responds to the fungus. In this review, we
will discuss recent advances in our understanding of the immune response toMalassezia
and how the implicated cells and cytokine pathways prevent uncontrolled fungal growth
to maintain commensalism in the mammalian skin. We also review how the antifungal
response is currently thought to affect the development and severity of inflammatory
disorders of the skin and at distant sites.
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INTRODUCTION
The skin, one of our body’s largest organs, harbors a wide variety of microbial communities,
including innocuous symbiotic organisms but also potential pathogens (Findley and Grice, 2014).
Advances in our understanding of the molecular mechanisms of microbial virulence and host
defense have improved the current view how dysbiosis and dysregulated immune responses against
commensal microbes drive pathological conditions (Chen et al., 2018).
Fungi are increasingly being recognized as common members of the microbiota. The most
prevalent fungi on the mammalian skin are those of the genus Malassezia, with >90% of all skin
fungi belonging to this genus (Findley et al., 2013). Currently, 18 species of Malassezia have been
identified, of which 10 were found in humans and the others in a growing number of animal hosts
(Guillot and Bond, 2020). Although generally viewed as a commensal, Malassezia has also been
associated with various dermatological conditions including mild diseases, such as dandruff and
pityriasis versicolor, to more severe inflammatory diseases, such as seborrheic dermatitis and atopic
dermatitis (AD) (Saunte et al., 2020). In rare cases, Malassezia has been reported to cause blood
stream infections (Iatta et al., 2014). In dogs, overgrowth ofMalassezia is associated with otitis and
dermatitis and treatment of such disorders with antifungals often improves the conditions (Bond
et al., 2020). In contrast to the situation in dogs, the association of Malassezia with skin disorders
in humans primarily relies on clinical association studies, while a causative relationship remains
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a matter of debate and the mechanism of pathogenesis unclear.
Dysbiosis with a higher fungal diversity and shifts in the relative
abundance of certain Malassezia species have been implicated
in AD. A large metagenomic study has reported an increase
in the relative abundance of M. dermatis and M. sympodialis
and a reduction of M. globosa on the skin of AD patients
(Chng et al., 2016). Lack of consensus with other studies on
the skin mycobiota in AD (Jo et al., 2017) may at least in part
be due to sampling biases and discrepancies between culture-
and sequence-based methods. In addition to the reported shifts
in the species distribution between normal and diseased skin,
intraspecies variations (Wu et al., 2015), which are known to alter
phenotype and function in other fungal species (Ropars et al.,
FIGURE 1 | The immune response to Malassezia is influenced by fungal factors including cell wall constituents and secreted components, inter- and intraspecies
variations and host factors such as genetics and skin or systemic predisposing conditions. These factors determine how Malassezia is recognized by the host and in
turn how the host responds to the fungus. The antifungal response is characterized by the activation of the IL-23/IL-17 axis, which not only controls fungal growth but
can also mediate immunopathology. AhR, aryl hydrocarbon receptor; CLR, C-type lectin receptor; γδ T, γδ T cells; ILC, innate lymphoid cells; TLR, Toll-like receptor;
TEWL, trans-epidermal water loss; Th, T helper cells.
2018), may further complicate the situation. The pathogenicity of
Malassezia spp. may also be modulated by mycoviruses that were
recently identified in some isolates (Clancey et al., 2019; Park
et al., 2019). Moreover, the microenvironment of the diseased
skin, which is characterized by barrier disruption, lipid deficiency
and elevated pH in case of AD (Weidinger and Novak, 2016), can
modulate the metabolism and thereby the functional properties
of the fungus (Chng et al., 2016). Inter-kingdom communications
within the skin microbiota may also influence the capacity of
Malassezia in promoting (or possibly preventing) skin disorders
(Li et al., 2017). Finally, host factors such as genetics, immune
status or comorbidities, can also influence the skin mycobiome
composition and pathogenic potential (Jo et al., 2017) (Figure 1).
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To understand the role of Malassezia in the development
and severity of skin diseases it is important to understand
the mechanisms of skin-fungus interactions in the (normal)
mammalian skin.
HOST RESPONSE TO THE SKIN
COMMENSAL YEAST MALASSEZIA
Constant exposure of the skin to commensal microbes results
in a continuous activation of the cutaneous immune system.
Active immunosurveillance of the microbiota is critical to
prevent dysbiosis, microbial overgrowth and translocation across
epithelial barriers as evidenced by the frequent occurrence
of opportunistic infections in immunodeficient individuals
(Pellicciotta et al., 2019).
Malassezia-host interactions are mediated via direct contacts
as well as indirectly via secreted factors (Velegraki et al., 2015)
and extracellular vesicles released from the fungus, which may
assist the delivery of soluble mediators to host cells (Johansson
et al., 2018; Zhang et al., 2019; Vallhov et al., 2020). These
interactions have been studied primarily in vitro with cultured
cells (Sparber and LeibundGut-Landmann, 2017). Reconstructed
human epidermis and ex vivo skin models, which reflect the
complexity of the skin more closely, have also been developed
to study the cutaneous antifungal response (Corzo-Leon et al.,
2019; Pedrosa et al., 2019). More recently, a murine model has
become available that provides insights into the host response
againstMalassezia in vivo. In contrast to in vitro systems, it allows
to study the contribution of circulating immune cells, which are
not normally resident in the skin, to the cutaneous host response
over prolonged periods of time (Sparber et al., 2019).
Toll-like receptors (TLRs) and C-type lectin receptors (CLRs)
recognize carbohydrates in the fungal cell wall (Plato et al., 2015).
Although the cell wall of Malassezia shows some differences to
that of other fungal genera and is covered by a lipid-rich outer
layer (Mittag, 1995; Kruppa et al., 2009; Stalhberger et al., 2014),
CLRs are thought to play a prominent role inMalassezia sensing.
Dectin-2 and Mincle have both been shown to bind Malassezia
cell wall constituents resulting in Malassezia phagocytosis and
cytokine production (Ishikawa et al., 2013; Haider et al., 2019).
However, in vivo the two receptors do not appear to be essential
for antifungal defense because knockout mice lacking either of
the two receptors do not manifest an impaired immune response
in the skin (Sparber et al., 2019). Functional redundancy between
the receptors and/or with other CLRs may provide a likely
explanation for reconciling the involvement of the downstream
signaling adaptor Card9 in the cutaneous response toMalassezia
(Sparber et al., 2019). The requirement of MyD88 for the
antifungal response (Sparber et al., 2019) may be explained by
the involvement of TLR2, which is also activated by Malassezia
(Baroni et al., 2006) (Figure 1).
Card9-mediated signaling couples innate fungal recognition
to the adaptive immune system, and importantly, it drives
polarization of CD4+ T cells into IL-17A-secreting effector
cells (LeibundGut-Landmann et al., 2007). While this was
first observed with Candida albicans in humans and mice
(LeibundGut-Landmann et al., 2007; Glocker et al., 2009), it
also applies to Malassezia: Malassezia-specific T helper cells
belong preferentially to the Th17 subset in both host species and
Malassezia-specific Th17 response is abolished in Card9-deficient
mice (Sparber et al., 2019).
αβ T cells are not the only IL-17A-producing cell type.
In the skin, γδ T cells and innate lymphoid cells (ILCs)
constitute prominent additional sources of IL-17A and respond
swiftly to cytokine stimulation in an antigen-independent
manner (Cua and Tato, 2010). Indeed, both γδ T cells and
ILCs secrete IL-17A in the skin of Malassezia-colonized mice
(Sparber et al., 2019) (Figure 1). Whether the activation of
γδ T cells and ILCs is a consequence of the experimental
infection and/or whether the innate cells contribute to long-term
immunosurveillance ofMalassezia commensalism, remains to be
determined. Intriguingly, the Card9 pathway does not seem to be
required for induction of innate IL-17A by Malassezia (Sparber
et al., 2019). This is reminiscent of what has been reported for
innate IL-17A induction in a murine model of oropharyngeal
candidiasis (Bishu et al., 2014), although the underlying cause
and the Card9-independent regulatory mechanisms are unclear
so far.
Complementary to classical pattern recognition receptors
such as CLRs, other classes of receptors are also implicated in
the recognition of Malassezia in the skin. They are particularly
relevant in keratinocytes, which lack Syk/Card9-coupled CLRs.
Examples of keratinocyte-fungal interactions are provided by
studies on C. albicans, which implicated receptors like E-
cadherin, EphA2, or EGFR in the antifungal response (Phan
et al., 2007; Swidergall et al., 2018; Ho et al., 2019). In case
of Malassezia, the aryl hydrocarbon receptor (AhR), a ligand-
dependent transcription factor, has gained attention because
Malassezia-derived metabolites, in particular indoles, can trigger
AhR signaling. Indole production was first reported for M.
furfur (Gaitanis et al., 2008), but other species of Malassezia
may also produce AhR ligands (Magiatis et al., 2013; Buommino
et al., 2018) (Figure 1). The activation of AhR signaling
can modulate skin homeostasis in manifold ways, including
oxidation, epidermal barrier function, melanogenesis, and innate
immunity (Furue et al., 2014). Importantly, AhR is implicated in
type 17 immunity by promoting Th17 differentiation (Quintana
et al., 2008; Veldhoen et al., 2008) and stimulating the
production of IL-17A and related cytokines by Th17 cells, innate
lymphocytes and ILCs (Veldhoen et al., 2008; Martin et al., 2009;
Qiu et al., 2012).Whether and howAhR signalingmodulates skin
immunity and in particular the type 17 response to Malassezia
remains an open question.
Consistently with the host-protective role of the IL-23/IL-17
immune axis in barrier tissues, IL-17 cytokines (including IL-
17A and IL-17F, and possibly the epithelial cell-derived family
member IL-17C, which is functionally related to IL-17A and
IL-17F) prevents Malassezia overgrowth on the murine skin
(Sparber et al., 2019). This is reminiscent of the well-known
activity of IL-17 against other fungi, in particular C. albicans,
on the skin and mucosal surfaces (Sparber and LeibundGut-
Landmann, 2019). In contrast to the prominent role of IL-17
in protection from mucocutaneous candidiasis, the mechanisms
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of immunosurveillance of Malassezia in humans are likely more
complex. No case has been reported to date where a genetic
defect in the IL-17 pathway or an upstream signaling element
manifests in detectable Malassezia overgrowth or development
of Malassezia-associated skin disorders. Of note, an increased
incidence of seborrheic dermatitis was reported as an adverse
event accompanying administration of the anti-IL-17A antibody
Ixekuzumab (Saeki et al., 2017), and a genetic variant of IL23R
was found associated with a decrease in dandruff (Ehm et al.,
2017). These observations support a link between the IL-23/IL-
17 immune axis and Malassezia in humans. More data are
needed to confirm these findings. Moreover, additional immune
mechanisms involved in the control ofMalassezia commensalism
await to be discovered.
MALASSEZIA-INDUCED IMMUNITY AND
IMMUNOPATHOLOGY IN THE SKIN
While type 17 immunity is primarily host-beneficial and supports
a protective state by controlling commensal fungi in barrier
tissues, IL-17 can also bear pathological potential if dysregulated.
The IL-17 pathway is a strong driver of inflammation in
several immune-mediated diseases, the prime example of which
is psoriasis (McGeachy et al., 2019). Mechanistically, IL-17
signaling induces not only the production of antimicrobial
peptides and tissue repair molecules, but also chemokines that
attract inflammatory myeloid cells to the tissue and it promotes
hyperproliferation of keratinocytes. The causative role of IL-
17 in psoriasis is demonstrated by the therapeutic efficacy of
neutralizing antibodies targeting IL-17 family cytokines and
receptors (Hawkes et al., 2017). Although the initial trigger of
the pathological IL-17 response in psoriasis is unknown, (skin)
fungal commensals are likely involved due to their prominent
IL-17-inducing capacity.
IL-17 has also been linked to AD (Koga et al., 2008),
although the causative relationship between the cytokine and
disease pathogenesis is less clear. It appears to be of particular
importance in subtypes of the disease (Leonardi et al., 2015; Noda
et al., 2015; Esaki et al., 2016). Staphylococcus aureus colonization
of the skin is among the most well-known hallmarks of AD
(Kong et al., 2012), and the induction of IL-17 in response to
epicutaneous S. aureus critically mediates skin inflammation in
an experimental setting (Liu et al., 2017; Nakagawa et al., 2017).
Likewise,Malassezia promotes skin inflammation under AD-like
conditions via the IL-23/IL-17 immune axis (Sparber et al., 2019).
Support for the contribution of Malassezia-induced IL-17 to
disease pathogenesis is further provided by the observation that
Malassezia-specific Th17 cells are enriched in AD patients (Balaji
et al., 2011; Sparber et al., 2019). Beyond AD, a link between the
IL-23/IL-17 immune axis and Malassezia-associated disorders
has also been proposed in seborrheic dermatitis (Wikramanayake
et al., 2018) and dandruff (Ehm et al., 2017). Besides the
prominent IL-17 profile,Malassezia-responsive T cells in humans
also produce IFN-γ (Balaji et al., 2011; Bacher et al., 2019; Sparber
et al., 2019), whereby the reason underlying the discrepancy
between the two host species remains unclear.
The association of Malassezia with AD was first based on the
observation that AD patients are often sensitized to Malassezia
with Th2 cells and IgE that are directed against the fungus
(Scalabrin et al., 1999; Zargari et al., 2001; Johansson et al.,
2002; Balaji et al., 2011). The Malassezia-specific IgE titers were
found to correlate with the severity of AD (Zhang et al., 2011;
Glatz et al., 2015), albeit their pathogenic role in AD is not
well-understood. An increase in Malassezia-specific serum IgE
was also documented in canine AD (Khantavee et al., 2019)
(Figure 1).
Important questions arise as to how Malassezia-specific Th2
cells are primed and whether they are a cause or a consequence
of the allergic response in the atopic skin environment. It also
remains unclear how the mixed Th2/Th17 response develops in
allergic individuals and how the Th cell subsets are related to
each other. Possible non-exclusive scenarios comprise that they
may result from differential polarization or selective outgrowth
of specific subsets. Clonotypic analysis of C. albicans-specific
T cell subsets revealed intraclonal functional heterogeneity in
support of a scenario of preferential outgrowth of individual
subsets (Becattini et al., 2015). Mixed Th2/Th17 populations
may also arise from T cell plasticity with intermediate T cells
co-producing IL-4 and IL-17A and co-expressing GATA3 and
RORγt as they have been observed in the blood and airways of
asthmatic patients (Cosmi et al., 2010; Wang et al., 2010; Irvin
et al., 2014) and in the skin of atopic individuals (Roesner et al.,
2015).
Regarding the mechanism how Malassezia-specific T cells
promote the allergic inflammation, it was speculated that cross-
reactivity may be involved and thereby add an autoimmune
component to the pathogenicity of AD. Among the Malassezia-
derived antigens that have been identified are some that
are phylogenetically highly conserved in mammals, such as
thioredoxin and manganese-dependent superoxide dismutase
(Schmid-Grendelmeier et al., 2005; Glaser et al., 2006; Balaji
et al., 2011). Alternatively, Malassezia-specific T cells may
also mediate immunopathology via cross-reactivity with other
microbes as recently reported for C. albicans-specific T cells
(Bacher et al., 2019). The emerging concept of cytokine-mediated
and T cell receptor-independent bystander activation of T cells
may represent another putative mechanism (Lee et al., 2019).
Given the pathogenic potential of the Malassezia-specific
immune response, tight regulation is required to maintain
commensalism. Induction of immune tolerance to skin
commensal microbes has been investigated in case of
Staphylococcus epidermidis. Antigen-specific regulatory T
cells (Tregs) that accumulate during a critical developmental
window in neonatal life were found important to balance
the antimicrobial Th17 effector cells directed against the
commensal (Scharschmidt et al., 2015). In a model of
fungal commensalism with C. albicans however, Tregs and
regulatory cytokines such as IL-10 appeared not essential for
immune homeostasis and stable persistence of the fungus in
the oral mucosa (Kirchner et al., 2019). Whether and how
immune regulation contributes to immunosurveillance and
prevents immunopathology in case of Malassezia remains
to be determined.
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The pathogenic effects of Malassezia in case of AD and
other inflammatory skin disorder may also be mediated by T
cell-independent mechanisms. Malassezia may promote disease
by triggering the production of pro-inflammatory mediators in
keratinocytes and tissue-resident immune cells in the atopic
skin that are more accessible to the fungus, owing to barrier
defects. Malassezia itself produces lipases and phospholipases
that generate free fatty acids, which can damage the integrity
of the skin and thereby might contribute to irritation and
inflammation (Dawson, 2007; Saunders et al., 2012). Malassezia
proteases may also interfere with cutaneous wound healing by
degrading extracellular matrix components (Poh et al., 2020).
While these various Malassezia-derived components have been
studied in vitro, their relevance for promoting inflammation in
the skin remains unclear. Complementary to the above described
scenarios, Malassezia may also influence disease by modulating
the virulence of other skin microbes such as S. aureus via inter-
kingdom interactions (Li et al., 2017). It was postulated that
such interactions could possibly be host beneficial rather than
disease promoting by attenuating bacterial biofilm formation
(Li et al., 2017), or by mechanisms such as those reported for
Staphylococcus interspecies interactions (Nakatsuji et al., 2017).
MALASSEZIA AND DISEASE BEYOND THE
SKIN
Aside from its abundance on the skin, Malassezia has also
been detected in extracutaneous sites. In particular, Malassezia
sequences have been identified in the gastrointestinal tract
in association with inflammatory bowel disease (IBD). Fungal
dysbiosis in IBD is characterized with an enrichment of fungal
taxa belonging to the Basidiomycota phylum, and this effect
was balanced by an equivalent decrease in taxa belonging to
the Ascomycota phylum (Sokol et al., 2017). More recently, in
an ITS1 sequencing analysis of intestinal washings, Malassezia
was associated with a subgroup of Crohn’s disease patients
carrying the CARD9 risk allele (Limon et al., 2019). Among
the Malassezia sequences, M. restricta was most abundant.
Relevance for the role of M. restricta in gut inflammation
was provided by the observation that gastrointestinal delivery
of the fungus aggravates the outcome of DSS-induced colitis
in mice in a Card9-dependent manner (Limon et al., 2019).
This phenotype was further linked to the induction of Th17
cells by M. restricta in the colonic lamina propria (Limon
et al., 2019), whereby IL-17 is involved in the pathogenesis
of disease in this model (Ito et al., 2008). It remains unclear
whether the detection of Malassezia by sequencing approaches
reflects transient relocation or true colonization of the gut by
the fungus. In addition, it is unknown whether Malassezia-
specific Th17 cells are involved in the pathogenesis of Crohn’s
disease, and if so, whether these cells get primed locally in
response to fungal dysbiosis, or whether they translocate from
the skin.
That Th17 cells directed against commensal fungi act at distal
sites from where they have been induced has also been observed
in other contexts with either host-protective or pathogenic
consequences. In gut colonization experiments, C. albicans-
induced Th17 cells protect from systemic candidiasis in a T
cell- and IL-17-dependent manner (Shao et al., 2019). The
protective effect extends to other extracellular pathogens, such
as S. aureus (Shao et al., 2019). These effects are complemented
by harmful consequences such as increased susceptibility to
airway inflammation and exacerbation of asthma-like symptoms
(Noverr et al., 2004; Shao et al., 2019). Besides these examples
from experimental models of C. albicans colonization in mice,
C. albicans-specific Th17 cells in human were also shown to
cross-react with A. fumigatus and to expand in patients with A.
fumigatus-driven lung pathology, suggesting an involvement in
allergic asthma (Bacher et al., 2019). Examples of a skin-lung
axis have been provided by bacterial skin commensals (Fyhrquist
et al., 2014). It is tempting to speculate that Th17 cells primed
againstMalassezia in the skinmay act in a similar way to promote
the progression from AD to allergic asthma and rhinitis and
thereby contribute to the atopic march.
Beyond its impact on the pathogenesis of inflammatory
diseases, Malassezia was recently implicated in carcinogenesis.
Among the microbes infiltrating pancreatic ductal adeno-
carcinomas (PDA) tumors, Malassezia was markedly enriched
(Aykut et al., 2019). In a murine model of PDA, Malassezia
exerted a tumor-promoting effect via a mechanism involving
mannose-binding lectin, a CLR and activator of complement and
implicated in antifungal innate immunity (Aykut et al., 2019).
Malassezia is likely a ligand of MBL, although direct binding
has not been demonstrated. Whether fungal dysbiosis is cause or
consequence of oncogenesis is not fully clear. The link between
Malassezia and carcinogenesis may be more general, as fungal
dysbiosis was also observed in colitis-associated cancer with an
enrichment ofMalassezia in the colonicmucosa associated fungal
microbiota (Richard et al., 2018).
CONCLUDING REMARKS
Recent advances in the field have shed light on the immune
response to Malassezia in the skin and on the divergent
consequences that the antifungal response can have on the host.
IL-17-dependent immunity against Malassezia contributes to
the maintenance of fungal commensalism and skin homeostasis.
The same pathway however can also have host-adverse
effects in predisposed individuals, and this effect is likely
not limited to the skin but also affects extracutaneous sites.
The factors determining these context-dependent outcomes
remain largely unclear. Moreover, it remains unknown
to what extent the effects of the antifungal immunity on
disease pathogenesis is shared or distinct between different
Malassezia-associated disorders. Beyond immunological
pathways, non-immunological factors such as neurotransmitters
and possibly hormones affect the antifungal response, and
this is likely also the case with Malassezia. Consistently,
neuroendocrine changes are known to impact the course and
severity of Malassezia-associated skin disorders. Future research
will inform about the potential of therapeutically targeting
fungal communities or the antifungal response for improving
patient outcome.
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